⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Insilico Medicine and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Insilico Medicine
↗Boston, USA
Insilico Medicine is a clinical-stage, end-to-end, generative artificial intelligence (AI)-driven biotechnology company. It leverages proprietary AI platforms—including PandaOmics, Chemistry42, and inClinico—to integrate biology, chemistry, and clinical trial analysis for the discovery and development of novel therapeutics.
The company focuses on addressing high unmet medical needs in areas such as oncology, fibrosis, immunology, central nervous system (CNS) diseases, and age-related conditions. Insilico is recognized for advancing the first generative AI-discovered and AI-designed drug candidate (rentosertib/ISM001-055) into human clinical trials.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Founded:2014
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Total Raised:$510M
Investors:Warburg Pincus, Value Partners, Qiming Venture Partners, Prosperity7 Ventures, Deerfield, Lilly Asia Ventures, Sequoia Capital China
STOCK
Exchange:HKEX
Ticker:3696.HK
Market Cap:$1B+
PIPELINE
Stage:Phase 2
Lead Drug Stage:Phase 2
Modalities:Small molecule
Active Trials:6
Trial Phases:Phase 2: 1
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:SK Biopharmaceuticals (Neuroimmune disorders), Sanofi (AI-driven drug discovery), Exelixis (USP1 inhibitor), Eli Lilly (AI drug discovery), Menarini Group
COMPETITION
Position:Leader
Competitors:BenevolentAI, Exscientia, Recursion Pharmaceuticals, Relay Therapeutics, Generate Biomedicines
LEADERSHIP
Key Executives:
Alex Zhavoronkov - Founder, CEO & CBO
Feng Ren - Co-CEO & CSO
Alex Aliper - President
Scientific Founders:Alex Zhavoronkov
Board Members:Andrew Adams, Michael Levitt, Denitsa Milanova, C.Y. Leung
LINKS
Website:insilicomedicine.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Insilico Medicine. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.